Ignite Creation Date:
2024-05-05 @ 7:21 PM
Last Modification Date:
2024-10-26 @ 9:47 AM
Study NCT ID:
NCT00654927
Status:
COMPLETED
Last Update Posted:
2012-03-02
First Post:
2008-04-04
Brief Title:
Open-Label Extension Study to Evaluate the Safety Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis
Sponsor:
Acorda Therapeutics
Organization:
Acorda Therapeutics
Organization Data
Organization:
Acorda Therapeutics
Class:
INDUSTRY
Study ID:
MS-F202 EXT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Acorda Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None